118 related articles for article (PubMed ID: 38581861)
1. Safety and efficacy of large-bore uncovered stents for treating malignant superior vena cava syndrome.
Lim Choi S; Il Gwon D; Ha Kim G; Won Kim S; Oh CH; Ko GY
Eur J Radiol; 2024 Jun; 175():111446. PubMed ID: 38581861
[TBL] [Abstract][Full Text] [Related]
2. Malignant superior vena cava syndrome: a comparative cohort study of treatment with covered stents versus uncovered stents.
Gwon DI; Ko GY; Kim JH; Shin JH; Yoon HK; Sung KB
Radiology; 2013 Mar; 266(3):979-87. PubMed ID: 23249571
[TBL] [Abstract][Full Text] [Related]
3. Covered stent placement for the treatment of malignant superior vena cava syndrome: is unilateral covered stenting safe and effective?
Cho Y; Gwon DI; Ko GY; Ko HK; Kim JH; Shin JH; Yoon HK; Sung KB
Korean J Radiol; 2014; 15(1):87-94. PubMed ID: 24497797
[TBL] [Abstract][Full Text] [Related]
4. Large-bore nitinol stents for malignant superior vena cava syndrome: factors influencing outcome.
Maleux G; Gillardin P; Fieuws S; Heye S; Vaninbroukx J; Nackaerts K
AJR Am J Roentgenol; 2013 Sep; 201(3):667-74. PubMed ID: 23971462
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes : long-term follow-up.
Breault S; Doenz F; Jouannic AM; Qanadli SD
Eur Radiol; 2017 Jan; 27(1):97-104. PubMed ID: 27085696
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Covered Versus Uncovered Stents for Benign Superior Vena Cava (SVC) Obstruction.
Haddad MM; Simmons B; McPhail IR; Kalra M; Neisen MJ; Johnson MP; Stockland AH; Andrews JC; Misra S; Bjarnason H
Cardiovasc Intervent Radiol; 2018 May; 41(5):712-717. PubMed ID: 29492630
[TBL] [Abstract][Full Text] [Related]
7. Bridging Stent Placement in Vena Cava Syndrome With Tumor Thrombotic Extension in the Right Atrium.
Zander T; Caro VD; Maynar M; Rabellino M
Vasc Endovascular Surg; 2021 Jan; 55(1):69-72. PubMed ID: 32862786
[TBL] [Abstract][Full Text] [Related]
8. Endovascular Treatment of Malignant Superior Vena Cava Syndrome through Upper-Limb Access: A Comparison between Venous-Dedicated and Conventional Stents.
Matthaiou N; Galanakis N; Kehagias E; Kontopodis N; Charalambous S; Kholcheva N; Tsetis K; Mavroudis D; Tsetis D
J Vasc Interv Radiol; 2020 Dec; 31(12):2066-2072. PubMed ID: 33127247
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous transluminal stenting for superior vena cava syndrome caused by malignant tumors: a single-center retrospective study.
Liu H; Li Y; Wang Y; Yan L; Zhou P; Han X
J Cardiothorac Surg; 2021 Mar; 16(1):39. PubMed ID: 33743767
[TBL] [Abstract][Full Text] [Related]
10. Endovascular stent-based revascularization of malignant superior vena cava syndrome with concomitant implantation of a port device using a dual venous approach.
Anton S; Oechtering T; Stahlberg E; Jacob F; Kleemann M; Barkhausen J; Goltz JP
Support Care Cancer; 2018 Jun; 26(6):1881-1888. PubMed ID: 29274029
[TBL] [Abstract][Full Text] [Related]
11. Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy.
Fagedet D; Thony F; Timsit JF; Rodiere M; Monnin-Bares V; Ferretti GR; Vesin A; Moro-Sibilot D
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):140-9. PubMed ID: 22146975
[TBL] [Abstract][Full Text] [Related]
12. Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause.
Büstgens FA; Loose R; Ficker JH; Wucherer M; Uder M; Adamus R
Rofo; 2017 May; 189(5):423-430. PubMed ID: 28152555
[No Abstract] [Full Text] [Related]
13. Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancer.
Calsina Juscafresa L; Gil Bazo I; Grochowicz L; Páramo Alfaro M; López-Picazo González JM; Moreno Jiménez M; Bilbao Jaureguizar JI
Hosp Pract (1995); 2017 Aug; 45(3):70-75. PubMed ID: 28618844
[TBL] [Abstract][Full Text] [Related]
14. Is Long-Term Anticoagulation Required after Stent Placement for Benign Superior Vena Cava Syndrome?
Haddad MM; Thompson SM; McPhail IR; Bendel EC; Kalra M; Stockland AH; Neidert NB; Andrews JC; Misra S; Bjarnason H; Neisen MJ
J Vasc Interv Radiol; 2018 Dec; 29(12):1741-1747. PubMed ID: 30396845
[TBL] [Abstract][Full Text] [Related]
15. Endovascular treatments of tunneled central venous catheter-induced superior vena cava complete occlusion via through-and-through technique.
Li N; Zeng N; Chen B; Huang Y
Hemodial Int; 2021 Jan; 25(1):35-42. PubMed ID: 33040490
[TBL] [Abstract][Full Text] [Related]
16. The role of self-expanding vascular stent in superior vena cava syndrome for advanced tumours.
Irace L; Martinelli O; Gattuso R; Mingoli A; Fiori E; Alunno A; Di Girolamo A; Crocetti D; Sapienza P
Ann R Coll Surg Engl; 2021 Apr; 103(4):296-301. PubMed ID: 33682470
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of stent placement for vena cava syndrome: phase II trial and phase III randomized controlled trial.
Takeuchi Y; Arai Y; Sone M; Sugawara S; Aramaki T; Sato R; Kichikawa K; Tanaka T; Morishita H; Ito T; Yamakado K; Baba Y; Kobayashi T
Support Care Cancer; 2019 Mar; 27(3):1081-1088. PubMed ID: 30112721
[TBL] [Abstract][Full Text] [Related]
18. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome.
Lanciego C; Pangua C; Chacón JI; Velasco J; Boy RC; Viana A; Cerezo S; García LG
AJR Am J Roentgenol; 2009 Aug; 193(2):549-58. PubMed ID: 19620456
[TBL] [Abstract][Full Text] [Related]
19. [Observation of endovascular stent insertion for non-small cell lung cancer patients with superior vena cava syndrome].
Li F; Sun X; Liang S; Jiang S; Mao L
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):47-51. PubMed ID: 25877319
[TBL] [Abstract][Full Text] [Related]
20. A new nitinol stent for use in superior vena cava syndrome. Initial clinical experience.
Andersen PE; Midtgaard A; Brenøe AS; Elle B; Duvnjak S
J Cardiovasc Surg (Torino); 2015 Dec; 56(6):877-81. PubMed ID: 26212865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
